<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Decreased <z:chebi fb="1" ids="18070">cytochrome c</z:chebi> oxidase (<z:chebi fb="12" ids="16236">CCO</z:chebi>) activity was found in various <z:e sem="disease" ids="C0027868" disease_type="Disease or Syndrome" abbrv="">neuromuscular diseases</z:e>, including infantile <z:hpo ids='HP_0007269'>spinal muscular atrophy</z:hpo> (SMA) and Fukuyama type <z:hpo ids='HP_0003741'>congenital muscular dystrophy</z:hpo> (FCMD), that was thought to result from a secondarily induced <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> defect </plain></SENT>
<SENT sid="1" pm="."><plain>To determine whether or not the enzyme activities in the <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> electron transport system can be secondarily changed, we measured the enzyme activities in denervated rat muscles </plain></SENT>
<SENT sid="2" pm="."><plain>The <z:chebi fb="12" ids="16236">CCO</z:chebi> activity decreased progressively to 38-47% of the control value in 3 weeks after denervation, the <z:chebi fb="0" ids="16908">NADH</z:chebi>-<z:chebi fb="1" ids="18070">cytochrome c</z:chebi> reductase and succinate-<z:chebi fb="1" ids="18070">cytochrome c</z:chebi> reductase activities remaining unchanged, suggesting that the <z:chebi fb="12" ids="16236">CCO</z:chebi> activity may be easily reduced secondarily in various disease conditions </plain></SENT>
</text></document>